93 related articles for article (PubMed ID: 8095323)
1. [A new beta-2 sympathomimetic drug with longer effectiveness. Comparison with current beta-2 sympathomimetic drugs in therapy of bronchial asthma in childhood].
von Berg A; Berdel D
Monatsschr Kinderheilkd; 1993 Jan; 141(1):53-8. PubMed ID: 8095323
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of formoterol and salbutamol on bronchial hyperreactivity and beta-adrenoceptor density on lymphocytes in children with bronchial asthma.
Kozlik-Feldmann R; von Berg A; Berdel D; Reinhardt D
Eur J Med Res; 1996 Jul; 1(10):465-70. PubMed ID: 9438143
[TBL] [Abstract][Full Text] [Related]
3. The use of inhaled formoterol in the treatment of asthma.
Berger WE
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
[TBL] [Abstract][Full Text] [Related]
4. State of the art in beta2-agonist therapy: a safety review of long-acting agents.
Rabe KF
Int J Clin Pract; 2003 Oct; 57(8):689-97. PubMed ID: 14627180
[TBL] [Abstract][Full Text] [Related]
5. [The effect of a single dose of formoterol using an aerosol inhaler in asthmatic children. A randomized, controlled, double-blind study].
Lebecque P; Vliers S; De Saint-Moulin T; Godding V
Rev Mal Respir; 1994; 11(1):47-50. PubMed ID: 7907426
[TBL] [Abstract][Full Text] [Related]
6. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
[TBL] [Abstract][Full Text] [Related]
7. [The effect of formoterol on light or moderate bronchial asthma due to allergy to Parietaria officinalis].
Pacor ML; Biasi D; Carletto A; Maleknia T; Lunardi C
Clin Ter; 1996 Nov; 147(11):567-70. PubMed ID: 9264910
[TBL] [Abstract][Full Text] [Related]
8. From adrenaline to formoterol: advances in beta-agonist therapy in the treatment of asthma.
Campbell LM
Int J Clin Pract; 2002 Dec; 56(10):783-90. PubMed ID: 12510953
[TBL] [Abstract][Full Text] [Related]
9. [Long-acting beta-2-agonists in the treatment of asthma].
Rochat T
Schweiz Med Wochenschr; 1994 Oct; 124(39):1714-9. PubMed ID: 7939538
[TBL] [Abstract][Full Text] [Related]
10. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of formoterol metered aerosol in children.
von Berg A; Berdel D
Lung; 1990; 168 Suppl():90-8. PubMed ID: 1974688
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
[TBL] [Abstract][Full Text] [Related]
13. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A
N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137
[TBL] [Abstract][Full Text] [Related]
14. The duration of action of inhaled formoterol dry powder.
Quebe-Fehling E; Brambilla R; Bromly CL; Fishwick K; Walters EH; Hendrick DJ
Br J Clin Pract; 1996 Dec; 50(8):446-9. PubMed ID: 9039716
[TBL] [Abstract][Full Text] [Related]
15. Sustained improvement in asthma with long-term use of formoterol fumarate.
Kesten S; Chapman KR; Broder I; Cartier A; Hyland RH; Knight A; Malo JL; Mazza JA; Moote DW; Small P
Ann Allergy; 1992 Nov; 69(5):415-20. PubMed ID: 1360774
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind trial of the effect of treatment with formoterol on clinical and inflammatory parameters of asthma in children.
Stelmach I; Gorski P; Jerzynska J; Stelmach W; Majak P; Kuna P
Ann Allergy Asthma Immunol; 2002 Jul; 89(1):67-73. PubMed ID: 12141723
[TBL] [Abstract][Full Text] [Related]
17. Different bronchodilating effect of salmeterol and formoterol in an adult asthmatic.
Ulrik CS; Kok-Jensen A
Eur Respir J; 1994 May; 7(5):1003-5. PubMed ID: 7914175
[TBL] [Abstract][Full Text] [Related]
18. Rapid onset of tolerance to beta-agonist bronchodilation.
Haney S; Hancox RJ
Respir Med; 2005 May; 99(5):566-71. PubMed ID: 15823453
[TBL] [Abstract][Full Text] [Related]
19. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE; Noonan MJ
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[TBL] [Abstract][Full Text] [Related]
20. Long-acting beta 2-agonists. Role in primary care asthma treatment.
D'Urzo AD
Can Fam Physician; 1997 Oct; 43():1773-7. PubMed ID: 9356758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
